This is a preview of subscription content, log in via an institution to check access.
Notes
2018 US dollars
Reference
GoodSmith MS, et al. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care : 26 Sep 2019. Available from: URL: http://doi.org/10.2337/dc19-0486
Rights and permissions
About this article
Cite this article
Biomarker screening plus genetic testing cost effective. PharmacoEcon Outcomes News 839, 10 (2019). https://doi.org/10.1007/s40274-019-6291-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6291-x